TapImmune to Provide Third Quarter 2017 Business Update Conference Call and Webcast

Company to Provide Corporate and Clinical Overview on Wednesday, November 15, 2017, at 4:30p.m. ET

[/vc_column_text][vc_column_text]JACKSONVILLE, FLORIDA – November 13, 2017 – TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced that the Company will host a conference call and live audio webcast on Wednesday, November 15, 2017, at 4:30p.m. ET, to provide a corporate and clinical update for the Third quarter 2017.

Reserve Your Seat: Register Today

The event will be webcast live via the Internet on:

November 15, 2017

4:30 p.m. ET

Click Here to register today, or visit https://www.webcaster4.com/Webcast/Page/1651/23491.

Day-of Call-in Information:

To access the live conference call, dial:

  • (855) 238-2333 (U.S.)
  • (412) 317-5215 (International)

To access the live audio webcast, visit the Events section of the TapImmune website https://www.markertherapeutics.com/events/. The webcast will also be archived for 90 days beginning at approximately 6:30 p.m. ET, on November 15, 2017.[/vc_column_text][vc_empty_space height=”8px”][vc_column_text][pr-disclaimer]